BioNet-Asia
is a Private company. BioNet-Asia has 4 followers on Owler. BioNet-Asia has an estimated revenue of <$1M and an estimate of less <10 employees.BioNet-Asia
is a Private company. BioNet-Asia has 4 followers on Owler. BioNet-Asia has an estimated revenue of <$1M and an estimate of less <10 employees.
CEO
Add
Est. Annual Revenue
<$1M
Est. Employees
<10
News
Dec 13, 2022
The Sun Daily
BioNet-Asia: Pharmaniaga, BioNet to collaborate on development of children's Hexavalent vaccine
Feb 01, 2022
Biospectrum Asia
BioNet-Asia: CEPI partners with BioNet to expand variant-proof vaccine programme
Jan 28, 2022
Medical Buyer
BioNet-Asia: BioNet earns up to $16.9M from CEPI
Nov 02, 2021
BioPharma-Reporter
BioNet-Asia: BioNet and BIA Separations develop optimized mRNA manufacturing process
Dec 17, 2018
FinanzNachrichten
BioNet-Asia: BioNet reports on persistence of antibody responses of recombinant pertussis vaccines in the Lancet Infectious Diseases
Sep 05, 2018
BioPortfolio
BioNet-Asia: DBV Technologies Geneva University Hospitals and BioNetAsia Presented Additional Phase I Data on the Use of an Investigational Epicutaneous Patch in Boosting Pertussis Vaccination at the ECI
Aug 29, 2017
PR Newswire
Press Release: BioNet-Asia : The HUG Completes the PertADO Trial Evaluating Pertagen®, a New Recombinant Pertussis Vaccine, in Adolescents in Switzerland.
Apr 20, 2017
FinanzNachrichten
BioNet-Asia: BioNet-Asia Organized International Pertussis Symposium Celebrating its 15th Anniversary in Bangkok
Mar 31, 2017
BioSpace
BioNet-Asia: DBV Tech, And Announce Phase I Trial Results Of Viaskin rPT In Pertussis Booster Vaccination
Dec 27, 2016
BioSpace
BioNet-Asia: <b>BioNet</b> Received Thai FDA Approval of the World's Only Available Recombinant Monovalent Acellular Pertussis (aP) Vaccine